A comparative study to assess the analgesic effect of bupivacaine and bupivacaine plus dexmedetomidine in pecs II block in breast surgery

Status

Active, not recruiting

Phases

Phase 4

Study type

Interventional

Source

PACTR

Registry ID

PACTR202009919065834

Enrollment

130

Registered

2020-09-21

Start date

2020-04-02

Completion date

Unknown

Last updated

2026-09-14

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Anaesthesia

Interventions

group C

Group Dex

Eligibility

Sex/Gender

Female

Inclusion criteria

Inclusion criteria: Their ages ranged between 18: 50 years old and Class I and II ASA physical status. scheduled for breast conservative surgery.

Exclusion criteria

Exclusion criteria: Patients with coagulation disorders, hepatic or renal impairment, previous chest surgery, uncooperative patients, skin infection at the puncture site , patient with a history of allergy to any of the study drugs

Design outcomes

Primary

Measure	Time frame
early onset of sensory block ,pronged time of first analgesic requirement, decrease dose of total morphine consumption	—

Secondary

Measure	Time frame
The onset of sensory block was significantly earlier in group Dex compared with group C. Time to first analgesic request was prolonged considerably in group Dex compared with group C. Total morphine consumption, and the number of patients requiring analgesia was significantly lower in group Dex in comparison with group C.	—

Countries

Egypt

Contacts

Public ContactSaad Saad

professor of anesthesia

saaddibrahim-7@yahoo.com00201223142889

Outcome results

None listed

Source: PACTR (via WHO ICTRP) · Data processed: Sep 19, 2026